Arcus Biosciences (RCUS) News Today $16.61 -0.29 (-1.72%) Closing price 10/16/2025 03:59 PM EasternExtended Trading$16.62 +0.02 (+0.09%) As of 09:17 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RCUS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Arcus Biosciences: Refusing To Let The TIGIT Story Die, And Finding Potential Niches In Huge MarketsOctober 16 at 2:30 PM | seekingalpha.comGilead and Arcus reignite anti-TIGIT interest with Phase II gastric cancer winOctober 15 at 10:36 AM | msn.comArcus Biosciences (NYSE:RCUS) Trading Down 6% - Should You Sell?October 14 at 2:59 PM | marketbeat.comCitigroup Maintains Arcus Biosciences (RCUS) Buy RecommendationOctober 14 at 4:30 AM | msn.comArcus Biosciences (RCUS) Is Up 14.9% After Positive Phase 2 Survival Data in Gastric Cancer—What's ChangedOctober 13, 2025 | uk.finance.yahoo.comArcus Biosciences stock rises after strong gastric cancer survival dataOctober 13, 2025 | za.investing.comArcus Biosciences (NYSE:RCUS) Shares Gap Up - Time to Buy?October 13, 2025 | marketbeat.comArcus Biosciences Turns Heads With 26.7-Month Survival In Gastric Cancer Study — Retail Calls It ‘Unprecedented’October 13, 2025 | msn.comArcus announces first OS results from Arm A1 of Phase 2 EDGE-Gastric studyOctober 13, 2025 | msn.comAnti-TIGIT Domvanalimab Plus Anti-PD-1 Zimberelimab and Chemotherapy Showed 26.7 Months of Median Overall Survival as First-Line Treatment of Unresectable or Advanced Gastroesophageal Adenocarcinomas in the Phase 2 EDGE-Gastric StudyOctober 12, 2025 | businesswire.comEvercore ISI Reaffirms Their Buy Rating on Arcus Biosciences (RCUS)October 10, 2025 | theglobeandmail.comInsider Selling: Arcus Biosciences (NYSE:RCUS) COO Sells 12,500 Shares of StockOctober 9, 2025 | marketbeat.comArcus Biosciences (NYSE:RCUS) COO Jennifer Jarrett Sells 37,792 Shares of StockOctober 9, 2025 | marketbeat.comArcus Biosciences Announces New Employment Inducement GrantsOctober 9, 2025 | businesswire.comBank of America Securities Sticks to Their Hold Rating for Arcus Biosciences (RCUS)October 9, 2025 | theglobeandmail.comArcus Biosciences (NYSE:RCUS) COO Jennifer Jarrett Sells 12,500 SharesOctober 9, 2025 | insidertrades.comWeiss Ratings Reaffirms "Sell (D-)" Rating for Arcus Biosciences (NYSE:RCUS)October 8, 2025 | marketbeat.comTruist Securities Reiterates Arcus Biosciences (RCUS) Buy RecommendationOctober 7, 2025 | msn.comA Fresh Look at Arcus Biosciences (RCUS) Valuation After New Casdatifan Data and Expanded Pipeline InitiativesOctober 7, 2025 | finance.yahoo.comArcus Biosciences, Inc. (RCUS) Shareholder/Analyst Call TranscriptOctober 6, 2025 | seekingalpha.comArcus Biosciences (NYSE:RCUS) Trading Up 15.2% - Here's What HappenedOctober 6, 2025 | marketbeat.comArcus Biosciences, Inc. (RCUS) Shareholder/Analyst Call - SlideshowOctober 6, 2025 | seekingalpha.comArcus Biosciences announces new data for casdatifanOctober 6, 2025 | msn.comArcus Biosciences stock soars after promising kidney cancer drug dataOctober 6, 2025 | investing.comArcus Biosciences Presents New Data for its HIF-2a Inhibitor Casdatifan and Discloses First Inflammation Programs at Investor EventOctober 6, 2025 | businesswire.comArcus Biosciences, Inc. (NYSE:RCUS) Receives Consensus Rating of "Moderate Buy" from AnalystsOctober 1, 2025 | marketbeat.comArcus Biosciences (NYSE:RCUS) CAO Alexander Azoy Sells 2,831 SharesSeptember 30, 2025 | marketbeat.comArcus Biosciences Announces New Employment Inducement GrantsSeptember 24, 2025 | businesswire.comArcus Biosciences, Inc. $RCUS Shares Purchased by Rhumbline AdvisersSeptember 20, 2025 | marketbeat.comArcus Biosciences, Inc. $RCUS Shares Purchased by Goldman Sachs Group Inc.September 16, 2025 | marketbeat.comArcus Biosciences, Inc. $RCUS Shares Acquired by Woodline Partners LPSeptember 12, 2025 | marketbeat.comArcus Biosciences (NYSE:RCUS) Stock Price Down 8% - Here's WhySeptember 10, 2025 | marketbeat.comArcus Biosciences, Inc. (RCUS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 10, 2025 | seekingalpha.comJacobs Levy Equity Management Inc. Acquires 506,853 Shares of Arcus Biosciences, Inc. $RCUSSeptember 10, 2025 | marketbeat.comArcus Biosciences Announces New Employment Inducement GrantsSeptember 8, 2025 | businesswire.comParkman Healthcare Partners LLC Has $9.54 Million Holdings in Arcus Biosciences, Inc. $RCUSSeptember 8, 2025 | marketbeat.comGranahan Investment Management LLC Purchases 133,497 Shares of Arcus Biosciences, Inc. $RCUSSeptember 8, 2025 | marketbeat.comArcus Biosciences, Inc. (NYSE:RCUS) Receives Consensus Rating of "Moderate Buy" from BrokeragesSeptember 8, 2025 | marketbeat.comTrexquant Investment LP Sells 85,182 Shares of Arcus Biosciences, Inc. $RCUSSeptember 7, 2025 | marketbeat.comAlexander Azoy Sells 1,579 Shares of Arcus Biosciences (NYSE:RCUS) StockSeptember 6, 2025 | insidertrades.comCutter Capital Management LP Purchases New Stake in Arcus Biosciences, Inc. $RCUSSeptember 6, 2025 | marketbeat.comArcus Biosciences, Inc. $RCUS Shares Sold by PDT Partners LLCSeptember 6, 2025 | marketbeat.comArcus Biosciences (NYSE:RCUS) Trading Up 8.5% - Should You Buy?September 5, 2025 | marketbeat.comRA Capital Management L.P. Takes Position in Arcus Biosciences, Inc. $RCUSSeptember 4, 2025 | marketbeat.comWalleye Capital LLC Takes $428,000 Position in Arcus Biosciences, Inc. $RCUSSeptember 4, 2025 | marketbeat.comThese 3 “Strong Buy” Value Stocks Have over 10% Upside, According to Analysts – 9/3/2025September 3, 2025 | msn.comArcus Biosciences, Inc. (RCUS) Presents At Citi's Biopharma Back To School Conference TranscriptSeptember 3, 2025 | seekingalpha.comRafferty Asset Management LLC Has $882,000 Position in Arcus Biosciences, Inc. $RCUSSeptember 3, 2025 | marketbeat.comNuveen LLC Takes Position in Arcus Biosciences, Inc. $RCUSSeptember 3, 2025 | marketbeat.comArcus Biosciences to Host Investor Event to Highlight its Late-Stage Casdatifan Program and Next Wave of Programs Focused on InflammationSeptember 2, 2025 | businesswire.com Get Arcus Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RCUS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RCUS Media Mentions By Week RCUS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCUS News Sentiment▼0.330.68▲Average Medical News Sentiment RCUS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCUS Articles This Week▼106▲RCUS Articles Average Week Get the Latest News and Ratings for RCUS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Arcus Biosciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Axsome Therapeutics News Today Legend Biotech News Today Vaxcyte News Today Metsera News Today Protagonist Therapeutics News Today TG Therapeutics News Today PTC Therapeutics News Today Krystal Biotech News Today Arrowhead Pharmaceuticals News Today Arcellx News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:RCUS) was last updated on 10/17/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcus Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcus Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.